RepliCel Life Sciences Inc (RP)
TSXV
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 121k | 252k | 353k | 354k | 353k | 353k |
Operating Income | -4.29M | -5.99M | -2.74M | -3.02M | -1.35M | -2.3M | -1.4M | -1.39M |
Pre Tax Income | -4.27M | -6.01M | -2.77M | -2.95M | -1.58M | -4.07M | -743k | -311k |
Net Income | -4.27M | -6.01M | -2.77M | -2.95M | -1.58M | -4.07M | -743k | -311k |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.273 | -0.28 | -0.103 | -0.104 | -0.053 | -0.117 | -0.016 | -0.005 |
EBIT | -4.29M | -5.99M | -2.74M | -2.94M | -1.57M | -3.37M | -454k | -326k |
EBITDA | -4.28M | -5.99M | -2.74M | -3.02M | -1.35M | -2.3M | -1.4M | -1.39M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.